Navigation Links
Leader Ventures Supports Innovative Drug Discovery Company Carmot
Date:12/20/2010

MENLO PARK, Calif., Dec. 20, 2010 /PRNewswire/ -- Leader Ventures, an investment firm offering blended debt and equity financing, today announced equipment financing to Carmot Therapeutics Inc., an innovative drug discovery company.

Chemotype Evolution, Carmot's proprietary drug-discovery platform invented by Carmot co-founders Stig K. Hansen and Daniel A. Erlanson while at Sunesis, is being used to identify promising drug candidates in a broad range of therapeutic areas.

"Leader's flexibility and understanding of our needs has been a tremendous source of support for Carmot, not only financially," said Stig K. Hansen, CEO at Carmot Therapeutics Inc. "We're looking forward to continuing to work with Leader Ventures as we grow and lead innovation in drug discovery."

"The leadership team is what first attracted us to Carmot," said Brian Best, managing director at Leader Ventures. "We then learned about the Chemotype Evolution technology platform making rapid identification of compounds for a wide variety of challenging disease targets a reality."

About Carmot Inc.Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing Chemotype Evolution. Carmot has licensed the technology and fragment libraries from Sunesis, and Carmot is in the process of further expanding the capabilities of Chemotype Evolution. Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen and Daniel A. Erlanson while they were working at Sunesis Pharmaceuticals.

About Leader Ventures: Leader Ventures is a private investment firm providing blended debt and equity financing to a diversified portfolio of private and public companies. With offices in San Francisco and Menlo Park, the firm invests primarily in the U.S. and employs a variety of loan plus equity structures to invest in companies at different developmental stages, across diverse industry segments.
'/>"/>

SOURCE Leader Ventures
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hospital to Hold MRSA Briefing for Media and Community Leaders
2. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
3. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
4. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
5. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
6. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
7. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
10. Nations Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections
11. Evalve Expands Executive Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
(Date:8/29/2014)... 2014  BC Technical, the nation,s leading non-OEM provider ... a leader in sales, service and installation of GE ... Technical to continue to expand their resources and inventory ... modalities. "We are committed to driving ... , president and CEO of BC Technical. "We set ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2
... Phase I data from XL880, Phase II data from ... SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixis, Inc. ... investigational compounds XL880 and XL999 will be,presented at the ... is being held June 1 to 5 in Chicago,Illinois. ...
... many as,first-line in secondary stroke prevention , ... presented today at the,16th European Stroke Conference in ... dipyridamole plus ASA,is marketed as Aggrenox® or Asasantin® ... vascular events in patients who had,a TIA or ...
Cached Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
(Date:8/31/2014)... Mesa, Arizona (PRWEB) August 31, 2014 For ... ragweed is likely the culprit. Ragweed is the most common ... percent of Americans. , The most common symptoms of ragweed ... and throat, and sneezing. Ragweed allergy can also lead to ... ragweed allergies should consult an allergist about allergy immunotherapy - ...
(Date:8/31/2014)... (PRWEB) September 01, 2014 In order to ... Co.,LTD has announced its latest designs and launched a big ... quality cars. , All the company’s new cars are ... car solutions for the global customers. As a matter of ... high end items. Those who are in need of cheap ...
(Date:8/31/2014)... 31, 2014 LabDoor.com tests the purity ... supplements. According to their website, “We buy products in ... retail stores and online sites. No manufacturer-supplied samples are ... “Stay Healthy with LabDoor,” a recent study was performed ... in the United States for Vitamin D3 content, ...
(Date:8/31/2014)... In the wake of growing consumer concerns ... to require mandatory labeling of GMOs on food and ... that affect their own health and the health of ... measures to eliminate GMOs from dietary supplements, NutriGold has ... initiative with the objective of advancing the non-GMO ...
(Date:8/31/2014)... St. Louis (PRWEB) August 31, 2014 Twin ... identical twins Aiden and Blake Colp before they were born, but ... Care Institute gave them the chance at life. , Now, ... TTTS and the life-saving fetal surgery option available in St. Louis ... TTTS awareness nights at Market Pub House (6655 Delmar Blvd, ...
Breaking Medicine News(10 mins):Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 2Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 3
... D,ALENE, Idaho, Feb. 28 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... radiology groups across the United States, today announced,that Ernest ... member of the,company,s Board of Directors for personal reasons. ... The company intends to immediately begin a search,to identify ...
... over Prior Year, NEW YORK, Feb. 28 HMS ... quarter and full,year ended December 31, 2007., Revenue for ... with $33.6 million for the same period a year ago. ... common share for the fourth,quarter of 2007, compared to net ...
... 28 VirtualHealth,Technologies, Inc. (OTC Bulletin Board: VHGI) President, ... that predict by 2017, total health,care spending will double ... of every $5 the nation spends according to a ... of the increased costs in health care,projected to top ...
... children with special health care needs, such as autism, ... the care that is federally recommended and that there ... standardized data at the national and state level has ... easily accessible way. , "Parents of children with special ...
... Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... Dale, President and CEO of,ATS Medical, and Mike ... Renshaw,"Straight to the Heart" conference at the Boston ... the conference is by invitation only. The,conference will ...
... Leonard, Founder and,Chief Surgeon of Leonard Hair Transplant Associates ... availability of a new genetic test for male,pattern baldness. ... England to,offer this to patients., Dr. Robert Leonard ... by genetic male pattern baldness. This exciting new tool ...
Cached Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Board Member Departure 2Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 2Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 3Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 4Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 5Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 6Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 7Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 8Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 9Health News:HMS Holdings Corp. Announces Q4 and Full Year 2007 Results 10Health News:As Healthcare Spending is Predicted to Exceed 4 Trillion in Less Than 10 Years, Technology will be Called upon to Stem the Tide 2Health News:New child health data show state-to-state differences in quality of care 2Health News:Dr. Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 2
One end with needle point and other end with medium taper. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches....
This double ended instrument was designed to lift and manipulate the corneal flap in Lasik procedures. Manufactured in titanium....
... This instrument marks the cornea for centration ... flap management in primary and enhancement cases. The ... used to ensure proper alignment of the flap ... atraumatically retract the flap and to flood it ...
Flat curved 1 mm spatula blade 30 mm long with marks at 5 mm, 6 mm and 7 mm from tip, polished finish and round knurled handle. Most popular size or model....
Medicine Products: